Shell Asset Management CO 10x Genomics, Inc. Transaction History

Shell Asset Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$36.95 - $82.41 $61,447 - $137,047	-1,663 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$135.05 - $182.59 $97,100 - $131,282	719 Added 76.17%	1,663 $248,000
Q3 2021 Nov 04, 2021	SELL	$145.58 - $192.14 $324,352 - $428,087	-2,228 Reduced 70.24%	944 $137,000
Q2 2021 Aug 12, 2021	BUY	$134.22 - $202.37 $384,406 - $579,587	2,864 Added 929.87%	3,172 $621,000
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $38,952 - $50,419	308 New	308 $44,000

287

94.9M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.54B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.